Top

International Journal of Clinical Pharmacy

Published in:

Open Access 01-10-2011 | Research Article

Factors related to high and low levels of drug adherence according to patients with type 2 diabetes

Authors: Sander D. Borgsteede, Marjan J. Westerman, Irene L. Kok, Joke C. Meeuse, Theo P. G. M. de Vries, Jacqueline G. Hugtenburg

Published in: International Journal of Clinical Pharmacy | Issue 5/2011

Abstract

Objective Adherence to medication in patients with type 2 diabetes varies widely, yet the factors that influence adherence according to patients are not fully known. The aim of this study is to explore both factors related to high and lower levels of adherence that patients with type 2 diabetes experienced in their medication use. Setting Primary care in the Netherlands. Method Qualitative, semi-structured interviews were performed in 20 patients with type 2 diabetes. Interviews were audio-taped and transcribed verbatim. Transcripts were coded and analysed using content analysis and constant comparison. Main outcome measure experiences and opinions of patients concerning factors related to high and lower levels of adherence. Results Comparable aspects influenced drug adherence in more and less adherent patients. Four aspects that influenced adherence to medication emerged from the interviews: (1) information about the prescribed medication, (2) experience with medication and complications with use, (3) social support for medication behaviour and (4) routines in medication behaviour. Experience with medication and social support for medication behaviour were related to high levels of adherence in some patients, and to lower levels of adherence in others. Complicated medication regimens were mainly related to lower adherence, while social support and routines in medication behaviour were related to higher adherence. Conclusions Routines in medication behaviour were related to higher drug adherence. Patient education should not only address information about the disease and medication, but also more practical issues concerning drug intake. Hence, to improve drug adherence in patients with type 2 diabetes, pharmaceutical care might be aimed at the counselling of patients to organise drug use in their daily schedule.

Sabaté E. Adherence to long-term therapies. In: WHO, editor. 2003. Geneva: WHO.

Cramer JA. A systematic review of adherence with medications for diabetes. Diabetes Care. 2004;27(5):1218–24.PubMedCrossRef

Morris LS, Schulz RM. Patient compliance—an overview. J Clin Pharm Ther. 1992;17(5):283–95.PubMed

Funnell MM, Anderson RM. MSJAMA: the problem with compliance in diabetes. JAMA. 2000;284(13):1709.PubMedCrossRef

Brown JB, Harris SB, Webster-Bogaert S, Wetmore S, Faulds C, Stewart M. The role of patient, physician and systemic factors in the management of type 2 diabetes mellitus. Fam Pract. 2002;19(4):344–9.PubMedCrossRef

Walker EA, Molitch M, Kramer MK, Kahn S, Ma Y, Edelstein S, et al. Adherence to preventive medications: predictors and outcomes in the diabetes prevention program. Diabetes Care. 2006;29(9):1997–2002.PubMedCrossRef

Pedan A, Varasteh L, Schneeweiss S. Analysis of factors associated with statin adherence in a hierarchical model considering physician, pharmacy, patient, and prescription characteristics. J Manag Care Pharm. 2007;13(6):487–96.PubMed

Mardby AC, Akerlind I, Jorgensen T. Beliefs about medicines and self-reported adherence among pharmacy clients. Patient Educ Couns. 2007;69(1–3):158–64.PubMed

Grant RW, Devita NG, Singer DE, Meigs JB. Polypharmacy and medication adherence in patients with type 2 diabetes. Diabetes Care. 2003;26(5):1408–12.PubMedCrossRef

10.

Vermeire E, Wens J, Van Royen P, Biot Y, Hearnshaw H, Lindenmeyer A. Interventions for improving adherence to treatment recommendations in people with type 2 diabetes mellitus. Cochrane Database Syst Rev. 2005;(2):CD003638.

11.

Haynes RB, Ackloo E, Sahota N, McDonald HP, Yao X. Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2008;(2):CD000011.

12.

Nurymberg K, Kreitler S, Weissler K. The cognitive orientation of compliance in short- and long-term type 2 diabetic patients. Patient Educ Couns. 1996;29(1):25–39.PubMedCrossRef

13.

Rubin RR. Adherence to pharmacologic therapy in patients with type 2 diabetes mellitus. Am J Med. 2005;118(Suppl 5A):27S–34S.PubMedCrossRef

14.

Morris LS, Schulz RM. Medication compliance: the patient’s perspective. Clin Ther. 1993;15(3):593–606.PubMed

15.

Grol R, Wensing M, Mainz J, Ferreira P, Hearnshaw H, Hjortdahl P, et al. Patients’ priorities with respect to general practice care: an international comparison. European task force on patient evaluations of general practice (EUROPEP). Fam Pract. 1999;16(1):4–11.PubMedCrossRef

16.

Vinter-Repalust N, Petricek G, Katic M. Obstacles which patients with type 2 diabetes meet while adhering to the therapeutic regimen in everyday life: qualitative study. Croat Med J. 2004;45(5):630–6.PubMed

17.

Vermeire E, Van Royen P, Wens J, Denekens J. The adherence of type 2 diabetes patients to their therapeutic regimens: a qualitative study from the patient’s perspective. Pract Diabetes Int. 2003;20(6):209–14.CrossRef

18.

Vermeire E, Hearnshaw H, Ratsep A, Levasseur G, Petek D, van Dam H, et al. Obstacles to adherence in living with type-2 diabetes: an international qualitative study using meta-ethnography (EUROBSTACLE). Prim Care Diabetes. 2007;1(1):25–33.PubMedCrossRef

19.

Samadhan A, Meeuse JC, Derraz S, Dusseljee T, Oirbans T, Borgsteede S, et al. Adherence to different drugs in patients with type II diabetes (abstract). Br J Clin Pharmacol. 2006;62(6):731.

20.

Horne R, Weinman J, Hankins M. The beliefs about medicines questionnaire: the development and evaluation of a new method for assessing the cognitive representation of medication. Psychol Health. 1999;14:1–24.CrossRef

21.

Fialko L, Garety PA, Kuipers E, Dunn G, Bebbington PE, Fowler D, et al. A large-scale validation study of the medication adherence rating scale (MARS). Schizophr Res. 2008;100(1–3):53–9.PubMedCrossRef

22.

Mason J. Qualitative researching. 2nd ed. London: Sage Publications; 2002.

23.

Bowskill R, Clatworthy J, Parham R, Rank T, Horne R. Patients’ perceptions of information received about medication prescribed for bipolar disorder: implications for informed choice. J Affect Disord. 2007;100(1–3):253–7.PubMedCrossRef

24.

George J, Kong DC, Thoman R, Stewart K. Factors associated with medication nonadherence in patients with COPD. Chest. 2005;128(5):3198–204.PubMedCrossRef

25.

WHO Collaborating Centre for Drug Statistics Methodology. ATC index with DDDs. Oslo: WHO; 2003.

26.

Dalgard OS. Social support—Definition and scope. http://www.euphix.org EUphact\Determinants of health\Environment\Social support (2009). Cited 4 Jan 2011.

27.

Veazie PJ, Cai S. A connection between medication adherence, patient sense of uniqueness, and the personalization of information. Med Hypotheses. 2007;68(2):335–42.PubMedCrossRef

28.

Ryan GW, Wagner GJ. Pill taking ‘routinization’: a critical factor to understanding episodic medication adherence. AIDS Care. 2003;15(6):795–806.PubMedCrossRef

29.

Hill-Briggs F, Cooper DC, Loman K, Brancati FL, Cooper LA. A qualitative study of problem solving and diabetes control in type 2 diabetes self-management. Diabetes Educ. 2003;29(6):1018–28.PubMedCrossRef

30.

Anderson RM, Funnell MM. Compliance and adherence are dysfunctional concepts in diabetes care. Diabetes Educ. 2000;26(4):597–604.PubMedCrossRef

31.

Wagner GJ, Ryan GW. Relationship between routinization of daily behaviors and medication adherence in HIV-positive drug users. AIDS Patient Care STDS. 2004;18(7):385–93.PubMedCrossRef

32.

Lindenmeyer A, Hearnshaw H, Vermeire E, Van Royen P, Wens J, Biot Y. Interventions to improve adherence to medication in people with type 2 diabetes mellitus: a review of the literature on the role of pharmacists. J Clin Pharm Ther. 2006;31(5):409–19.PubMedCrossRef

33.

Tordoff J, Simonsen K, Thomson WM, Norris PT. “It’s just routine.” A qualitative study of medicine-taking amongst older people in New Zealand. Pharm World Sci. 2010;32(2):154–61.PubMedCrossRef

34.

Harvey JN, Lawson VL. The importance of health belief models in determining self-care behaviour in diabetes. Diabetic Med. 2009;26(1):5–13.PubMedCrossRef

35.

Wens J, Vermeire E, Hearnshaw H, Lindenmeyer A, Biot Y, Van Royen P. Educational interventions aiming at improving adherence to treatment recommendations in type 2 diabetes: a sub-analysis of a systematic review of randomised controlled trials. Diabetes Res Clin Pract. 2008;79(3):377–88.PubMedCrossRef

36.

Thorne S, Paterson B, Russell C. The structure of everyday self-care decision making in chronic illness. Qual Health Res. 2003;13(10):1337–52.PubMedCrossRef

37.

Velligan DI, Wang M, Diamond P, Glahn DC, Castillo D, Bendle S, et al. Relationships among subjective and objective measures of adherence to oral antipsychotic medications. Psychiatr Serv. 2007;58(9):1187–92.PubMedCrossRef

38.

Malpass A, Andrews R, Turner KM. Patients with Type 2 Diabetes experiences of making multiple lifestyle changes: a qualitative study. Patient Educ Couns. 2009;74(2):258–63.PubMedCrossRef

39.

Reach G. Role of habit in adherence to medical treatment. Diabetic Med. 2005;22(4):415–20.PubMedCrossRef

Title: Factors related to high and low levels of drug adherence according to patients with type 2 diabetes
Authors: Sander D. Borgsteede
Marjan J. Westerman
Irene L. Kok
Joke C. Meeuse
Theo P. G. M. de Vries
Jacqueline G. Hugtenburg
Publication date: 01-10-2011
Publisher: Springer Netherlands
Published in: International Journal of Clinical Pharmacy / Issue 5/2011
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI: https://doi.org/10.1007/s11096-011-9534-x

ACC 2024 Congress Coverage

Heart Failure Video

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Factors related to high and low levels of drug adherence according to patients with type 2 diabetes

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 5/2011

Self-medication practices among adult population attending community pharmacies in Malaysia: an exploratory study

Determinants of self medication practices among pregnant women in Ibadan, Nigeria

Comparative safety of antipsychotics in the WHO pharmacovigilance database: the haloperidol case

Gender and use of hypnotics or sedatives in old age: a nationwide register-based study

Information sources used by parents buying non-prescription medicines in pharmacies for preschool children

Oxycodone induced delirium and agitation in an elderly patient following total right knee arthroplasty

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page